University of California

Abbott Laboratories Corporation

Abbott Molecular Inc.

Matthew Frankel

George J Dawson

Charles Chiu

Kevin Y Cheng

Kelly Coller

Deanna Lee

Michael Berg

Kenn Forberg

John R Hackett, Jr

John R Hackett

George H Schneider

John Hackett

Provided herein are compositions, methods, and kits for detecting human2 (HPgV-2). In certain embodiments, provided herein are HPgV-2 specific nucleic acid probes and primers, and methods for detecting HPgV-2 nucleic acid. In other embodiments, provided herein are HPgV-2 immunogenic composition compositions, methods of treating a subject with immunogenic HPgV-2 peptides, and methods of detecting HPgV-2 subject antibodies in a sample.

Compositions and methods for detecting human pegivirus 2 (HPgV-2)

The invention is directed to compositions, kits, and methods for amplifying and detecting a Zika virus nucleic acid sequence in a sample, which comprises a variety of combinations of forward oligonucleotide primers, reverse oligonucleotide primers, and oligonucleotide probes.

Compositions and methods for detecting zika virus

Provided herein are compositions, methods, and kits for detecting human Pegivirus 2 (HPgV-2). In certain embodiments, provided herein are HPgV-2 specific nucleic acid probes and primers, and methods for detecting HPgV-2 nucleic acid. In other embodiments, provided herein are HPgV-2 immunogenic composition compositions, methods of treating a subject with immunogenic HPgV-2 peptides, and methods of detecting HPgV-2 subject antibodies in a sample.

Compositions and methods for detecting human Pegivirus 2 (HPgV-2)

Growing community of inventors

Abbott Park, IL, United States of America

Matthew Frankel